Invesco Biotechnology & Genome ETF
PBE
PBE
97 hedge funds and large institutions have $73M invested in Invesco Biotechnology & Genome ETF in 2021 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 23 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
97
Holders Change
+3
Holders Change %
+3.19%
% of All Funds
1.7%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
12
Reduced
23
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
AWA
1
Artemis Wealth Advisors
New York
|
$4.08M |
| 2 |
2
Goldman Sachs
New York
|
$1.01M |
| 3 |
3
Stifel Financial
St. Louis,
Missouri
|
$2.18M |
| 4 |
CC
4
Cypress Capital
Franklin,
Tennessee
|
$282K |
| 5 |
5
LPL Financial
San Diego,
California
|
$3.03M |
